Wall Street shuffled its fearful feet on Tuesday, November 18, 2025, as investors digested a buffet of macroeconomic reports, corporate news, and political drama—the kind of day that makes even seasoned traders wish for a stronger coffee and perhaps, a bar of…
Monday was a classic "hold your horses" day, with Wall Street digesting fresh economic data, tariff news, and awaiting Nvidia’s AI-focused earnings report later this week. Stock indices retreated modestly but maintain strong YTD performance, investors eyeing the yield curve and FOMC…
Merck (MRK), ever the discerning giant of Big Pharma, has decided to join the prophylactic party by acquiring Cidara Therapeutics (CDTX) for a headline-grabbing $9.2 billion—a move that whispers both “strategic pipeline expansion” and “Keytruda’s patent clock is ticking, folks.” In a…
If scorekeepers gave points for wit, this week would earn an honorable mention—showcasing the market’s ability to sprint, stumble, and get up again before anyone starts playing the national anthem. Investors, however, are left pondering what comes next, armed with quarterly reports,…
Equities ended the session notably weaker after a volatile day characterized by renewed selling in tech and high-growth names. Major indices closed lower, with the Nasdaq Composite leading declines among the big three benchmarks. The day’s moves underscored a shift in risk…
The major indices closed with a mixed tone after a session of careful balance between safety in value plays and the still-ambitious tilt toward growth. The S&P 500 eked out a gain, the Dow inched into positive territory as fresh macro cues…
In honor of Veterans Day, the market brought both rally and resilience, as portfolio generals weighed AI ambition against time-honored value plays. Whether saluting S&P records or commiserating with Nasdaq laggards, investors marched onward—sometimes in formation, sometimes in hopeful disorder, and always…
Stocks soared Monday, November 10, 2025, with a rally that could make even the most seasoned bear consider a hibernation sabbatical. Wall Street’s major indexes leapt as Congress inched closer to ending the record-breaking government shutdown, unleashing the kind of risk-on mood…
Cogent Biosciences (COGT) and GeoVax Labs (GOVX) offered investors and clinicians fresh cause for cautious celebration this week, both releasing data-laden news that—if not quite cocktail-hour material—could at least liven up a Monday earnings call with a smidgen of biotech bravado.…
Wall Street’s week wrapped with less of a bow and more of a sigh, as major indexes retreated under a cloud of AI valuation skepticism, limp labor data, and Capitol Hill’s existential drama over the government shutdown, which cost the economy an…
